NYSE:SNN

Smith & Nephew - SNN Stock Forecast, Price & News

$22.63

+0.68 (+3.10%)

(As of 09/28/2022 12:00 AM ET)

Add

Compare

Today's Range: $21.95
▼
$22.72
50-Day Range: $21.95
▼
$29.35
52-Week Range: $21.77
▼
$37.28

Volume: 1.29 million shs
Average Volume: 1.69 million shs
Market Capitalization: $9.85 billion

P/E Ratio: N/A
Dividend Yield: 4.12%
Price Target: N/A

Smith & Nephew MarketRank™ Forecast

Analyst Rating: N/A
Upside/Downside: N/A
Short Interest: Healthy
0.87% of Float Sold Short
Dividend Strength: Moderate
Based on Four Factors
Sustainability: N/A
News Sentiment: -0.04
Based on 5 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: 12.10%
From $1.57 to $1.76 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.51 out of 5 stars

Medical Sector

1026th out of 1,096 stocks

Surgical Appliances & Supplies Industry

22nd out of 24 stocks

N/A

Analyst's Opinion

Consensus Rating
There is not enough analysis data for Smith & Nephew.

3.0

Short Interest

Percentage of Shares Shorted
0.87% of the float of Smith & Nephew has been sold short.
Short Interest Ratio / Days to Cover
Smith & Nephew has a short interest ratio ("days to cover") of 3.1, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Smith & Nephew has recently increased by 62.50%, indicating that investor sentiment is decreasing significantly.

2.5

Dividend Strength

Dividend Leadership
Smith & Nephew is a leading dividend payer. It pays a dividend yield of 4.12%, putting its dividend yield in the top 25% of dividend-paying stocks.
Dividend Growth
Smith & Nephew does not have a long track record of dividend growth.
Dividend Sustainability
Based on earnings estimates, Smith & Nephew will have a dividend payout ratio of 51.14% next year. This indicates that Smith & Nephew will be able to sustain or increase its dividend.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for SNN.

1.1

News and Social Media Coverage

News Sentiment
Smith & Nephew has a news sentiment score of -0.04. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.78 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 5 news articles for Smith & Nephew this week, compared to 1 article on an average week.
Search Interest
Only 3 people have searched for SNN on MarketBeat in the last 30 days. This is a decrease of -25% compared to the previous 30 days.
MarketBeat Follows
Only 3 people have added Smith & Nephew to their MarketBeat watchlist in the last 30 days. This is a decrease of -77% compared to the previous 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Smith & Nephew insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 1.00% of the stock of Smith & Nephew is held by insiders.
Percentage Held by Institutions
Only 8.56% of the stock of Smith & Nephew is held by institutions.

1.3

Earnings and Valuation

Earnings Growth
Earnings for Smith & Nephew are expected to grow by 12.10% in the coming year, from $1.57 to $1.76 per share.
Price to Earnings Growth Ratio
Smith & Nephew has a PEG Ratio of 2.18. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Smith & Nephew has a P/B Ratio of 1.79. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Smith & Nephew (NYSE:SNN) Stock

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

Receive SNN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Smith & Nephew and its competitors with MarketBeat's FREE daily newsletter.

SNN Stock News Headlines

September 29, 2022 | americanbankingnews.com

Brokerages Set Smith & Nephew plc (NYSE:SNN) PT at $1,396.00

September 26, 2022 | seekingalpha.com

Smith & Nephew: Still A Buy Despite Short-Term Challenges

September 23, 2022 | americanbankingnews.com

Smith & Nephew (NYSE:SNN) Reaches New 52-Week Low at $23.47

September 16, 2022 | nasdaq.com

First Week of November 18th Options Trading For Smith & Nephew (SNN)

September 14, 2022 | finance.yahoo.com

Smith & Nephew's Implant Shows 86% Reduction In Re-Tear Rates After Shoulder Surgery

September 14, 2022 | finance.yahoo.com

New randomized controlled trial shows that addition of Smith+Nephew's REGENETEN™ Bioinductive Implant delivers 86% reduction in rotator cuff re-tear rates at 12 months

August 9, 2022 | uk.finance.yahoo.com

Another day, another profits warning – but here's why you should stick by Smith & Nephew

August 5, 2022 | finance.yahoo.com

Is There An Opportunity With Smith & Nephew plc's (LON:SN.) 36% Undervaluation?

August 4, 2022 | finance.yahoo.com

Smith+Nephew's OXINIUM™ Technology Tour of Change touches down at the Pro Football Hall of Fame during enshrinement weekend

June 16, 2022 | msn.com

Political leaders clash over Smith & Nephew move to leave Hull

June 16, 2022 | bbc.com

Smith & Nephew: Hull Labour group asks government to step in

June 14, 2022 | finance.yahoo.com

SMITH+NEPHEW SHARES NEW RESEARCH THAT ESTIMATES 3.5 BILLION HOURS OF NURSE TIME COULD BE RELEASED BY 2030 THROUGH SHARED WOUND CARE AND USE OF LONG-WEAR ADVANCED FOAM DRESSINGS

June 9, 2022 | finanznachrichten.de

Smith & Nephew plc: Smith+Nephew announces new UK R&D and manufacturing facility for Advanced Wound Management with $100m+ investment near Hull

June 8, 2022 | finance.yahoo.com

Smith+Nephew announces first total hip replacement cases on its CORI™ Surgical System using RI.HIP MODELER and RI.HIP NAVIGATION

June 1, 2022 | seekingalpha.com

Smith & Nephew sells 2 wound-healing cell therapies to Healiva

June 1, 2022 | seekingalpha.com

Smith & Nephew: Fair Price For An Attractive Medical Devices Supplier

April 28, 2022 | seekingalpha.com

Smith & Nephew reports Q1 results

April 4, 2022 | finance.yahoo.com

Should Weakness in Smith & Nephew plc's (LON:SN.) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

March 31, 2022 | finance.yahoo.com

Form 8.3 - SNN LN Equity 28-March-22 Dealing Disclosure (AMENDMENT)

March 29, 2022 | finance.yahoo.com

Form 8.3 - SNN LN Equity 28-March-22 Dealing Disclosure

March 28, 2022 | finance.yahoo.com

Form 8.3 - SNN LN Equity 25-March-22 Dealing Disclosure

March 17, 2022 | uk.finance.yahoo.com

Top investment tips for a stocks and shares ISA

March 4, 2022 | benzinga.com

Redburn Partners Upgrades Smith & Nephew to Neutral

February 26, 2022 | finance.yahoo.com

Smith & Nephew plc Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

February 22, 2022 | msn.com

MARKET REPORT: Smith & Nephew surges after boss's shock exit

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive SNN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Smith & Nephew and its competitors with MarketBeat's FREE daily newsletter.

SNN Company Calendar

Last Earnings: 11/17/2014
Today: 9/29/2022
Ex-Dividend for 10/26 Dividend: 9/29/2022
Dividend Payable: 10/26/2022
Fiscal Year End: 12/31/2022

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Surgical appliances & supplies
Sub-Industry: N/A
Sector: Medical
Current Symbol: NYSE:SNN
CUSIP: N/A
CIK: 845982
Web: www.smith-nephew.com
Phone: 441923477100
Fax: 44-20-7930-3353
Employees: 18,000
Year Founded: 1856

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: 14.41
P/E Growth: 2.18
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 0.42
Current Ratio: 1.78
Quick Ratio: 0.84

Sales & Book Value

Annual Sales: $5.21 billion
Price / Sales: 1.89
Cash Flow: $2.99 per share
Price / Cash Flow: 7.56
Book Value: $12.66 per share
Price / Book: 1.79

Miscellaneous

Outstanding Shares: 435,300,000
Free Float: 430,951,000
Market Cap: $9.85 billion
Optionable: Optionable
Beta: 0.62

Social Links

Key Executives

Ms. Anne-Francoise Nesmes (Age 50)
CFO & Exec. Director
Comp: $1.71M

Dr. Deepak S. Nath Ph.D. (Age 49)
CEO & Director

Mr. Paul Connolly (Age 54)
Pres of Global Operations

Mr. Andrew Swift
VP of Investor Relations

Ms. Helen Barraclough (Age 43)
Group Gen. Counsel, Company Sec. & Director

Ms. Alison Parkes (Age 50)
Chief Compliance Officer

Mr. Joe Metzger
Sr. VP of Marketing Services & Communications

Ms. Elga Lohler (Age 54)
Chief HR Officer

Mr. Philip G. Cowdy (Age 55)
Chief Bus. Devel. & Corp. Affairs Officer

Mr. Bradley Cannon (Age 54)
Pres of Orthopaedics, Sports Medicine & ENT and Americas

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

SNN Stock - Frequently Asked Questions

Should I buy or sell Smith & Nephew stock right now?: 7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Smith & Nephew in the last year. There are currently 4 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" SNN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SNN, but not buy additional shares or sell existing shares.
View SNN analyst ratings or view top-rated stocks.
How have SNN shares performed in 2022?: Smith & Nephew's stock was trading at $34.62 at the start of the year. Since then, SNN stock has decreased by 34.6% and is now trading at $22.63.
View the best growth stocks for 2022 here.
Are investors shorting Smith & Nephew?: Smith & Nephew saw a increase in short interest in the month of September. As of September 15th, there was short interest totaling 3,770,000 shares, an increase of 62.5% from the August 31st total of 2,320,000 shares. Based on an average daily volume of 1,210,000 shares, the short-interest ratio is presently 3.1 days. Approximately 0.9% of the company's shares are short sold.
View Smith & Nephew's Short Interest.
How were Smith & Nephew's earnings last quarter?: Smith & Nephew plc (NYSE:SNN) issued its earnings results on Monday, November, 17th. The medical equipment provider reported $0.98 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.39 by $0.59.
How often does Smith & Nephew pay dividends? What is the dividend yield for Smith & Nephew?: Smith & Nephew announced a semi-annual dividend on Monday, August 1st. Stockholders of record on Friday, September 30th will be paid a dividend of $0.288 per share on Wednesday, October 26th. This represents a yield of 2.8%. The ex-dividend date of this dividend is Thursday, September 29th.
Read our dividend analysis for SNN.
Is Smith & Nephew a good dividend stock?: Smith & Nephew (NYSE:SNN) pays an annual dividend of $0.90 per share and currently has a dividend yield of 4.10%. SNN has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
Read our dividend analysis for SNN.

What other stocks do shareholders of Smith & Nephew own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Smith & Nephew investors own include Smith & Nephew (SN), RPM International (RPM), Gilead Sciences (GILD), AbbVie (ABBV), Alibaba Group (BABA), Johnson & Johnson (JNJ), Pfizer (PFE), Abbott Laboratories (ABT), Alexion Pharmaceuticals (ALXN) and Amgen (AMGN).
What is Smith & Nephew's stock symbol?: Smith & Nephew trades on the New York Stock Exchange (NYSE) under the ticker symbol "SNN."
Who are Smith & Nephew's major shareholders?: Smith & Nephew's stock is owned by many different retail and institutional investors. Top institutional investors include Nuance Investments LLC (2.51%), Lazard Asset Management LLC (0.36%), Wells Fargo & Company MN (0.22%), JPMorgan Chase & Co. (0.12%), FMR LLC (0.11%) and Goldman Sachs Group Inc. (0.09%).
How do I buy shares of Smith & Nephew?: Shares of SNN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Smith & Nephew's stock price today?: One share of SNN stock can currently be purchased for approximately $22.63.
How much money does Smith & Nephew make?: Smith & Nephew (NYSE:SNN) has a market capitalization of $9.85 billion and generates $5.21 billion in revenue each year.
How many employees does Smith & Nephew have?: The company employs 18,000 workers across the globe.
How can I contact Smith & Nephew?: Smith & Nephew's mailing address is BUILDING 5 CROXLEY PARK HATTERS LANE, WATFORD X0, WD18 8YE. The official website for the company is www.smith-nephew.com. The medical equipment provider can be reached via phone at 441923477100, via email at andrew.swift@smith-nephew.com, or via fax at 44-20-7930-3353.

This page (NYSE:SNN) was last updated on 9/29/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Smith & Nephew - SNN Stock Forecast, Price & News

Smith & Nephew MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows